SWOG clinical trial number
SWOG-8691 (INT-0073)

(INT-0073), A Randomized Comparison of Deoxycoformycin Versus Alpha-Interferon in Previously Untreated Patients With Hairy Cell Leukemia

Closed
Phase
Accrual
100%
Published
Abbreviated Title
(INT-0073), A Randomized Comparison of Deoxycoformycin Versus Alpha-Interferon in Previously Untreated Patients With Hairy Cell Leukemia
Activated
12/15/1986
Closed
10/01/1991

Research committees

Leukemia

Publication Information Expand/Collapse

2018

Value of Anti-Cancer Drugs in SWOG Phase III Clinical Trials: Evidence from Multiple Evaluation Mechanisms

V Nghiem;R Vaidya;M Banegas;D Hershman;J Unger AcademyHealth Annual Research Meeting (June 23-26, 2018, Seattle, WA), poster #B-335

2008

The Southwest Oncology Group: progress in cancer research [PMID18929152]

CA Coltman Seminars in Oncology 35(5):545-552

2000

Long-term follow-up of remission duration, mortality and second malignancies in hairy cell leukemia patients treated with pentostatin

IW Flinn;KJ Kopecky;MK Foucar;D Head;J Bennett;R Hutchison;W Corbett;P Cassileth;T Habermann;H Golomb;K Rai;E Eisenhauer;F Appelbaum;B Cheson;MR Grever Blood 96(9):2981-2986

1999

Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2'-deoxycoformycin and prediction of early relapse

MS Tallman;D Hakimian;KJ Kopecky;S Wheaton;E Wollins;K Foucar;PA Cassileth;T Haberman;M Grever;JM Rowe;LC Peterson Clinical Cancer Research 5:1665-1670

1997

Long-term results in hairy cell leukemia (HCL) treated with pentostatin.

IW Flinn;KJ Kopecky;MK Foucar;D Head;JM Bennett;RE Hutchison;WEN Corbett;PA Cassileth;T Habermann;H Golomb;K Rai;E Eisenhauer;FR Appelbaum;BD Cheson;M Grever Blood 90(10)Suppl.1:578a(#2575)

1995

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: An Intergroup study

M Grever;K Kopecky;MK Foucar;D Head;JM Bennett;RE Hutchison;WEN Corbett;PA Cassileth;T Habermann;H Golomb;K Rai;E Eisenhauer;F Appelbaum;BD Cheson Journal of Clinical Oncology 13(4):974-982

1992

A randomized comparison of deoxycofomycin (DCF) versus alpha-2a interferon (IFN) in previously untreated patients with hairy cell leukemia (HCL): An NCI-sponsored intergroup study. (SWOG, ECOG, CALGB, NCIC-CTG).

M Grever;K Kopecky;D Head;P Cassileth;H Golomb;T Habermann;K Rai;E Eisenhauer;B Cheson ASCO 11:264(#868)

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/A042001

A Randomized Phase II Study Comparing Inotuzumab Plus Chemotherapy Versus Standard Chemotherapy in Older Adults with Philadelphia-Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
Research Committee(s)
Leukemia
Activated
02/27/2023
Open
Phase
SWOG Clinical Trial Number
S1925

A Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia (CLL): EVOLVE CLL Study.
Research Committee(s)
Leukemia
Lymphoma
Symptom Control and Quality of Life
Activated
12/14/2020
Accrual
49%
Open
Phase
SWOG Clinical Trial Number
CTSU/AALL1821

A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination with Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old with First Relapse
Research Committee(s)
Leukemia
Activated
12/04/2020
Open